Loading clinical trials...
Loading clinical trials...
Growth and Plasma Amino Acid Levels in Infants With Cow's Milk Protein Allergy and Treated With a Newly Innovated Amino Acid Formula (NAAF) Compared to a Commercial Amino Acid Formula (AAF)
The purpose of this study is to determine growth and protein status of infants with cow's milk protein allergy and treated with a newly innovated amino acid formula compared to those with a commercial amino acid formula.
Severe cases of cow's milk protein allergy are treated with the amino acid formula. The amino acid formula is composed of essential and non-essential amino acids, vegetable oils with or without MCT oil, and glucose polymer from various carbohydrate sources. Such formula is also fortified by minerals, trace elements,and vitamins.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
Yes
Faculty of Medicine Siriraj Hospital
Bangkok, Thailand
Start Date
April 1, 2013
Primary Completion Date
June 30, 2023
Completion Date
July 31, 2023
Last Updated
March 24, 2023
81
ACTUAL participants
Comparison of treatment with different amino acid formulas
DIETARY_SUPPLEMENT
Lead Sponsor
Mahidol University
NCT05785299
NCT04249973
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04184700